Home: Maucher Jenkins

Intellectual Property

Patents | Trade Marks | Designs

News and Events

NewsEvents

High Court throws out claim for loss under the 'unlawful means' tort

Date: 22 January 2018

By Reuben Jacob and Dr. Janet Strath

 

Secretary for State for Health v Servier Laboratories Ltd, [2017] EWHC 2006 (Ch), 2 August 2017, 

 

In the latest chapter of litigation involving Servier's branded perindopril drug, Coversyl, the High Court has struck out a claim for damages for loss caused by unlawful means.

 

It was alleged that misrepresentations made to the European Patent Office (EPO) in the course of an application for a patent (which was later revoked), as well as an interim injunction application to enforce the patent pending trial—with the intention of securing grant of the patent, delaying generic entry into the perindopril market and achieving elevated prices in respect of Servier's supply of perindopril to that market—had caused loss to the claimant English Health Authorities. However, Mr Justice Roth found case law dictated the tort required, among other things, that the alleged unlawful means had to affect the freedom of the third party to deal with the claimant; in this case, 'the "third party" are the EPO and the English court, and there is no question of interference with their "freedom to deal" with the English Health Authorities, or indeed with anyone else'. Accordingly, the ground of claim alleging loss caused by unlawful means had to be struck out as falling outside the scope of that tort.

 

The full article is available here and was first published in the Journal of Intellectual Property Law & Practice on 12 January 2017.

 

For questions about this matter or related issues, please contact our Partner Reuben Jacob (reuben.jacob@maucherjenkins.com).

To ensure we give you the best experience on our website we use Cookies. You can change your cookie settings at any time. However, if you continue without changing your settings we will presume you are happy to receive all cookies on the Maucher Jenkins website.

Continue